Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12154
Title: Chronic calcium antagonist therapy: some unexpected results.
Austin Authors: Nayler, W G;Sturrock, W J;Dillon, J S
Affiliation: Department of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia
Issue Date: 16-May-1988
Publication information: Journal of Cardiovascular Pharmacology; 12 Suppl 6(): S79-82
Abstract: The calcium antagonists protect the myocardium against the deleterious effects of ischemia and postischemic reperfusion provided that they are used prophylactically. This requires chronic therapy. Experiments were undertaken to establish whether chronic verapamil therapy alters the cardiac noradrenaline reserves or provokes a change in beta 1 adrenoceptor density. Sprague-Dawley (SD) rats were fed a diet containing placebo, or placebo plus dl verapamil (V) to provide plasma V levels of around 100 ng/ml. After 6 weeks of therapy the hearts were excised and assayed for noradrenaline (NA), adrenaline (A), and dopamine (DA) using high performance liquid chromatography. In addition, cardiac membranes were isolated in the presence of Tris, 10 mM MgCl2 and 9 microM phenylmethylsulfoxylfluoride and assayed for beta 1 adrenoceptor density (Bmax) and affinity (KD), using [3H]dihydroalprenolol as the ligand. Three days of therapy reduced left ventricular NA by 45%. Asymptote was reached within 11 days, when the NA content has decreased (p less than 0.001) to only 0.9 +/- 0.1 mu/g dry wt, mean +/- SEM, n = 6. The tissue level of DA was also reduced from 0.14 +/- 0.02 to 0.08 +/- 0.01 microgram/g dry weight (p less than 0.02). Further treatment for up to 6 weeks caused no further change in NA, A, or DA. Even after 6 weeks of therapy the density (35.5 +/- 1.9 before and 31.2 +/- 2.3 fmol/mg protein after therapy) and affinity (0.24 +/- 0.02 and 0.21 +/- 0.02 nM) of the beta 1 adrenoceptors were unchanged. These results show that although chronic verapamil therapy depletes the cardiac reserves of NA, beta-adrenoceptor density remains constant.
Gov't Doc #: 2468914
URI: https://ahro.austin.org.au/austinjspui/handle/1/12154
Journal: Journal of Cardiovascular Pharmacology
URL: https://pubmed.ncbi.nlm.nih.gov/2468914
Type: Journal Article
Subjects: Animals
Calcium Channel Blockers.adverse effects
Male
Membranes.drug effects.metabolism
Norepinephrine.blood
Rats
Rats, Inbred Strains
Receptors, Adrenergic, beta.drug effects.metabolism
Verapamil.adverse effects.blood
Appears in Collections:Journal articles

Show full item record

Page view(s)

12
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.